» Articles » PMID: 3367788

Secondary Hyperparathyroidism of Morbid Obesity Regresses During Weight Reduction

Overview
Journal Metabolism
Specialty Endocrinology
Date 1988 May 1
PMID 3367788
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In order to test the relation between obesity and the secondary hyperparathyroidism found in markedly overweight subjects, 24 morbidly obese patients were studied before and after a weight loss of 35.9 kg obtained by a nutritionally adequate, intermittent very-low-calorie diet. Overweight was reduced from 98 +/- 34% to 44 +/- 19%. Serum total calcium did not change, but serum ionized calcium (Ca2+) increased from 1.22 +/- 0.04 mmol/L to 1.25 +/- 0.04 mmol/L (P less than .001). A corresponding fall was observed in serum parathyroid hormone (s-PTH), which decreased from 47.2 +/- 21.7 pmol/L to 35.2 +/- 19.4 pmol/L (P = .01). The change of s-PTH was positively associated with the reduction of body weight (r = .50, P less than .05) and with the reduction of overweight (r = .55, P less than .01). Regarding calcium binding substances, serum albumin remained low. The initially lowered serum phosphate and bicarbonate both rose (P less than .001). Plasma lactate and plasma free fatty acids (FFAs) decreased (P less than .001). The study supports our hypothesis that the change profile of calcium complexing anions in obesity interferes with the tubular reabsorption of calcium, which in turn lowers serum Ca2+, thus promoting hyperparathyroidism. Along with weight loss, concentrations of calcium complexing anions returns towards normal values and the secondary hyperparathyroidism regresses.

Citing Articles

Forearm Fractures in Overweight-Obese Children and Adolescents: A Matter of Bone Density, Bone Geometry or Body Composition?.

Franceschi R, Radetti G, Soffiati M, Maines E Calcif Tissue Int. 2022; 111(2):107-115.

PMID: 35316361 DOI: 10.1007/s00223-022-00971-3.


Update on the Crosstalk Between Adipose Tissue and Mineral Balance in General Population and Chronic Kidney Disease.

Karava V, Christoforidis A, Kondou A, Dotis J, Printza N Front Pediatr. 2021; 9:696942.

PMID: 34422722 PMC: 8378583. DOI: 10.3389/fped.2021.696942.


Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial.

Vix M, Liu K, Diana M, DUrso A, Mutter D, Marescaux J Surg Endosc. 2013; 28(3):821-6.

PMID: 24196556 DOI: 10.1007/s00464-013-3276-x.


Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.

Grethen E, Hill K, Jones R, Cacucci B, Gupta C, Acton A J Clin Endocrinol Metab. 2012; 97(5):1655-62.

PMID: 22362819 PMC: 3339883. DOI: 10.1210/jc.2011-2280.


The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity.

Sukumar D, Partridge N, Wang X, Shapses S J Clin Endocrinol Metab. 2011; 96(6):1852-8.

PMID: 21508136 PMC: 3206398. DOI: 10.1210/jc.2010-2781.